2024-07-212244.27 MB45页20
2024-07-21224976.43 KB11页29
2024-07-23223945.65 KB7页9
2024-07-222233.07 MB64页7
2024-07-212232.78 MB34页13
2024-07-172233.77 MB58页11
2024-07-172231.49 MB50页21
2024-07-172233.16 MB35页2
2024-07-172224.81 MB48页13
2024-07-172221.67 MB6页5
2024-08-0722115.86 MB246页6
2024-07-232211.21 MB118页14
2024-07-212215.61 MB23页22
2024-07-212212.88 MB33页9
2024-07-1722112.6 MB76页29
2024-07-172214.64 MB59页20
2024-07-1722111.84 MB36页6
2024-08-012203.4 MB31页2
2024-07-1722045.43 MB53页5
“中国新靶点”数据分析赋能未满足临床需求药物研发王中健博士享融智云CEOhttps://www.pharnexcloud.com/目录CONTENTS01新药研发现状及热门靶点概述02深入挖掘“中国新靶点”03各适应症“中国新靶点”分析04总结https://www.pharnexcloud.com/全球新药数量分阶段统计124,521国内首家研发企业43,909国外首家研发企业80,61215,5905,0224,9266,1163,0271,413774787药物发现12,5634,1521,6155,329334临床前4604723,609II期临床1,281... 2024-07-172208.18 MB31页24